MICHAEL MAGGIO: Open Payments
NPI 1417501412 · WARREN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 14 payments from 11 companies in 2025. Trend: 2023 $1,410 · 2024 $1,552 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
| ABBVIE INC. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Tris Pharma Inc | 1 | $17 |
| Alkermes, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: Qelbree, VRAYLAR, FANAPT, REXULTI, SPRAVATO, CAPLYTA, Jornay PM, Dyanavel XR.
Industry payments across OH — which companies pay providers there.
